HIV-1 (human immunodeficiency virus-1) integrase inhibitor tablet and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- TIANJIN INT JOINT ACADEMY OF BIOTECH & MEDICINE
- Publication Date
- 2017-08-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of pharmacy, in particular to an HIV-1 integrase inhibitor tablet and a preparation method thereof. Background technique
[0002] AIDS (acquired immunodeficiency syndrome, referred to as AIDS) has developed into a global disease since it was first diagnosed in the United States in 1981. So far, AIDS has become one of the most important epidemic diseases in the world. According to the latest statistics from UNAIDS, there are 35.3 million people living with AIDS worldwide, and 1.6 million people died of AIDS-related diseases in 2012. In 1983, Montgnier Bare-Sinoussi and others confirmed that the pathogen of AIDS is human immunodeficiency virus (human immunodeficiency virus, referred to as HIV), by killing or destroying the human immune system, a series of opportunistic infections and tumors are concurrent, and severe cases can lead to die. The replication cycle of HIV is divided into adsorption, penetration, uncoatin...